Sort
21,281 grants matching “influenza”
Project I: Immunity to Influenza in Primary Lung Epithelial Cells
$261,171Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Identification of Host Drug Development Targets in Influenza Using Transposon Mutagenesis
$261,000Adam Lacy-Hulbert · Benaroya Research Inst At Virginia Mason · R21 · FY2016 · AI
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
$261,000Michael Schotsaert · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · AI
Bacterial cell envelope in polar positioning of autotransporter proteins
$261,000Marcia B Goldberg · Massachusetts General Hospital · R21 · FY2015 · AI
Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis
$261,000Stephen I. Pelton · Boston Medical Center · R21 · FY2015 · DC
Dysregulated Co-inhibitory Pathways Associated with Severe COVID-19 Immunopathology
$260,931David A. Hafler · Yale University · P01 · FY2020 · AI
Mindfulness to Improve Elders' Immune and Health Status
$260,926Jan A Moynihan · University Of Rochester · R01 · FY2008 · AG
Asthma Clinical Research Network-Washington University
$260,893Mario Castro · Washington University · U10 · FY2007 · HL
Immunobiology of the DsrA protein of H. ducreyi
$260,887Christopher Elkins · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI
Innate Immune Properties of Airway Epithelium
$260,882University Of Iowa · P50 · FY2003 · HL
Peru Infectious Diseases Epidemiology Research Training Consortium
$260,878Andres G Lescano · Universidad Peruana Cayetano Heredia · D43 · FY2018 · TW
Peru Infectious Diseases Epidemiology Research Training Consortium
$260,877Andres G Lescano · Universidad Peruana Cayetano Heredia · D43 · FY2016 · TW
Potentiating broadly protective local immunity to influenza virus
$260,771Andrea Janine Sant · University Of Rochester · R21 · FY2019 · AI
CHEMOKINES IN THE IMMUNE RESPONSE TO A VIRAL INFECTION
$260,745La Jolla Inst For Allergy &Immunolgy · R01 · FY2001 · AI
Development of Recombinant SARS VLP Vaccines
$260,726Novavax, Inc. · U01 · FY2005 · AI
Immunity to SARS-CoV-2 After Natural Infection or Vaccination
$260,724Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
World of Viruses
$260,705Judy Diamond · University Of Nebraska Lincoln · R25 · FY2007 · RR
Adjuvant Enhanced Antiviral Immunity
$260,688Jeff C Fairman · Juvaris Biotherapeutics, Inc. · U01 · FY2011 · AI
Cross Reacting Polysaccharides (H. influenzae types a and b, and B. pumilus)
$260,665Rachel Schneerson · Child Health And Human Development · Z01 · FY2007 · HD
Interference by Defective influenza Viruses
$260,604Debi P. Nayak · University Of California Los Angeles · R01 · FY2006 · AI
Class II Processing Delineated by Flu Glycoproteins
$260,513Laurence Crane Eisenlohr · Thomas Jefferson University · R01 · FY2007 · AI
Targeting viral alkaline nucleases for the development of broad spectrum anti-herpesvirus therapeutics
$260,500Sandra K Weller · University Of Connecticut Sch Of Med/Dnt · R21 · FY2019 · AI
Regulation of Local B Cell Responses to Influenza Under Conditions of Infection,
$260,489Jan S. Erikson · University Of Pennsylvania · U19 · FY2011 · AI
Regulatory T Cell Activity in Anti-Viral Immunity
$260,487Andrew J Caton · University Of Pennsylvania · U19 · FY2011 · AI
Enabling Technology to Screen and Quantify Sialylated Structures for Activity Against Viral Enzymes and Receptors
$260,432Lisa A Holland · West Virginia University · R01 · FY2024 · GM